AbbVie (ABBV) Income Statement & Earnings

219.680
-5.690-2.52%

Close Mar 13 16:00 ET

219.600
-0.080-0.04%

Post 20:01 ET

388.43BMarket Cap93.08P/E (TTM)

AbbVie (ABBV) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

8.57%61.16B

10.04%16.62B

9.10%15.78B

6.65%15.42B

8.39%13.34B

3.71%56.33B

5.60%15.1B

3.83%14.46B

4.31%14.46B

0.70%12.31B

Operating revenue

8.57%61.16B

10.04%16.62B

9.10%15.78B

6.65%15.42B

8.39%13.34B

3.71%56.33B

5.60%15.1B

3.83%14.46B

4.31%14.46B

0.70%12.31B

Cost of revenue

7.69%18.2B

3.55%4.55B

25.93%5.3B

3.43%4.35B

-2.25%4B

-17.20%16.9B

-22.93%4.4B

-35.05%4.21B

-0.90%4.2B

2.71%4.09B

Gross profit

8.94%42.96B

12.70%12.07B

2.19%10.47B

7.96%11.08B

13.69%9.34B

16.30%39.43B

24.53%10.71B

37.70%10.25B

6.60%10.26B

-0.28%8.22B

Operating expense

-16.96%22.87B

-41.09%6.26B

-7.06%5.89B

0.66%5.36B

2.02%5.36B

35.19%27.54B

107.46%10.62B

24.34%6.34B

10.20%5.33B

-1.26%5.25B

Selling and administrative expenses

-5.03%14.01B

1.04%3.9B

-15.12%3.57B

-3.67%3.25B

-0.66%3.29B

14.61%14.75B

20.73%3.86B

24.70%4.21B

3.34%3.38B

9.08%3.32B

Research and development costs

-28.89%9.1B

-61.93%2.58B

8.87%2.32B

9.39%2.13B

6.60%2.07B

66.66%12.79B

251.53%6.77B

23.62%2.13B

12.41%1.95B

-15.40%1.94B

Other operating expenses

-3,342.86%-241M

---217M

----

---24M

----

96.09%-7M

----

Operating profit

68.92%20.09B

6,815.48%5.81B

17.15%4.58B

15.85%5.72B

34.40%3.98B

-12.12%11.89B

-97.58%84M

66.72%3.91B

2.96%4.94B

1.51%2.96B

Net non-operating interest income expense

-21.62%-2.63B

-7.38%-655M

-12.86%-667M

-33.99%-678M

-38.41%-627M

-28.27%-2.16B

-61.38%-610M

-48.49%-591M

-11.45%-506M

0.22%-453M

Non-operating interest income

-58.95%266M

-35.87%59M

-44.19%72M

-71.82%62M

-64.73%73M

20.00%648M

-50.54%92M

-17.83%129M

124.49%220M

109.09%207M

Non-operating interest expense

3.03%2.89B

1.71%714M

2.64%739M

1.93%740M

6.06%700M

26.26%2.81B

24.47%702M

29.73%720M

31.52%726M

19.35%660M

Other net income (expense)

-80.57%-10.87B

-42.63%-2.49B

-158.72%-3.2B

-52.65%-3.49B

-124.54%-1.69B

-7.45%-6.02B

7.63%-1.74B

-31,050.00%-1.24B

-32.04%-2.28B

62.09%-754M

Gain on sale of security

-176.19%-58M

42.11%-11M

-766.67%-20M

-2,200.00%-23M

0.00%-4M

85.62%-21M

61.22%-19M

112.00%3M

97.30%-1M

88.57%-4M

Special income (charges)

-81.94%-5.02B

19.63%-1.27B

-3,168.29%-2.68B

12.17%-823M

-51.22%-248M

-254.37%-2.76B

-458.16%-1.57B

-24.24%-82M

-234.64%-937M

-9.33%-164M

-Less:Other special charges

81.94%5.02B

-19.63%1.27B

3,168.29%2.68B

-12.17%823M

51.22%248M

254.37%2.76B

458.16%1.57B

24.24%82M

234.64%937M

9.33%164M

Other non- operating income (expenses)

-78.80%-5.79B

-706.67%-1.21B

56.60%-503M

-96.21%-2.64B

-145.90%-1.44B

30.72%-3.24B

90.36%-150M

-1,320.00%-1.16B

4.75%-1.35B

67.52%-586M

Income before tax

77.53%6.6B

217.58%2.67B

-65.74%714M

-27.59%1.55B

-5.36%1.66B

-40.54%3.72B

-287.21%-2.27B

6.71%2.08B

-17.78%2.15B

269.47%1.76B

Income tax

514.74%2.36B

137.98%853M

1.15%526M

-20.70%613M

-2.87%372M

-141.39%-570M

-678.87%-2.25B

202.33%520M

32.59%773M

63.68%383M

Net income

-1.24%4.23B

7,991.30%1.82B

-87.98%188M

-31.46%941M

-6.05%1.29B

-12.05%4.29B

-102.79%-23M

-12.18%1.56B

-32.26%1.37B

469.29%1.37B

Net income continuous Operations

-1.24%4.23B

7,991.30%1.82B

-87.98%188M

-31.46%941M

-6.05%1.29B

-12.05%4.29B

-102.79%-23M

-12.18%1.56B

-32.26%1.37B

469.29%1.37B

Minority interest income

-12.50%7M

0.00%-1M

-33.33%2M

0.00%3M

-20.00%8M

-150.00%-1M

0.00%3M

50.00%3M

Net income attributable to the parent company

-1.22%4.23B

8,354.55%1.82B

-88.08%186M

-31.53%938M

-6.06%1.29B

-12.03%4.28B

-102.68%-22M

-12.20%1.56B

-32.31%1.37B

472.80%1.37B

Preferred stock dividends

Other preferred stock dividends

0.00%40M

0.00%10M

-6.98%40M

-9.09%10M

Net income attributable to common stockholders

-1.23%4.19B

5,743.75%1.81B

-88.65%176M

-31.76%928M

-6.11%1.28B

-12.07%4.24B

-103.95%-32M

-12.22%1.55B

-32.44%1.36B

496.05%1.36B

Basic earnings per share

-1.25%2.37

8,342.16%1.0272

-88.64%0.1

-32.47%0.52

-6.49%0.72

-12.09%2.4

-102.68%-0.0125

-12.00%0.88

-32.46%0.77

492.31%0.77

Diluted earnings per share

-0.84%2.37

5,200.00%1.02

-88.64%0.1

-32.47%0.52

-6.49%0.72

-12.13%2.39

-104.35%-0.02

-12.00%0.88

-32.46%0.77

492.31%0.77

Dividend per share

5.81%6.56

5.81%1.64

4.73%6.2

4.73%1.55

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	8.57%61.16B	10.04%16.62B	9.10%15.78B	6.65%15.42B	8.39%13.34B	3.71%56.33B	5.60%15.1B	3.83%14.46B	4.31%14.46B	0.70%12.31B
Operating revenue	8.57%61.16B	10.04%16.62B	9.10%15.78B	6.65%15.42B	8.39%13.34B	3.71%56.33B	5.60%15.1B	3.83%14.46B	4.31%14.46B	0.70%12.31B
Cost of revenue	7.69%18.2B	3.55%4.55B	25.93%5.3B	3.43%4.35B	-2.25%4B	-17.20%16.9B	-22.93%4.4B	-35.05%4.21B	-0.90%4.2B	2.71%4.09B
Gross profit	8.94%42.96B	12.70%12.07B	2.19%10.47B	7.96%11.08B	13.69%9.34B	16.30%39.43B	24.53%10.71B	37.70%10.25B	6.60%10.26B	-0.28%8.22B
Operating expense	-16.96%22.87B	-41.09%6.26B	-7.06%5.89B	0.66%5.36B	2.02%5.36B	35.19%27.54B	107.46%10.62B	24.34%6.34B	10.20%5.33B	-1.26%5.25B
Selling and administrative expenses	-5.03%14.01B	1.04%3.9B	-15.12%3.57B	-3.67%3.25B	-0.66%3.29B	14.61%14.75B	20.73%3.86B	24.70%4.21B	3.34%3.38B	9.08%3.32B
Research and development costs	-28.89%9.1B	-61.93%2.58B	8.87%2.32B	9.39%2.13B	6.60%2.07B	66.66%12.79B	251.53%6.77B	23.62%2.13B	12.41%1.95B	-15.40%1.94B
Other operating expenses	-3,342.86%-241M	---217M	----	---24M	----	96.09%-7M	----	----	----	----
Operating profit	68.92%20.09B	6,815.48%5.81B	17.15%4.58B	15.85%5.72B	34.40%3.98B	-12.12%11.89B	-97.58%84M	66.72%3.91B	2.96%4.94B	1.51%2.96B
Net non-operating interest income expense	-21.62%-2.63B	-7.38%-655M	-12.86%-667M	-33.99%-678M	-38.41%-627M	-28.27%-2.16B	-61.38%-610M	-48.49%-591M	-11.45%-506M	0.22%-453M
Non-operating interest income	-58.95%266M	-35.87%59M	-44.19%72M	-71.82%62M	-64.73%73M	20.00%648M	-50.54%92M	-17.83%129M	124.49%220M	109.09%207M
Non-operating interest expense	3.03%2.89B	1.71%714M	2.64%739M	1.93%740M	6.06%700M	26.26%2.81B	24.47%702M	29.73%720M	31.52%726M	19.35%660M
Other net income (expense)	-80.57%-10.87B	-42.63%-2.49B	-158.72%-3.2B	-52.65%-3.49B	-124.54%-1.69B	-7.45%-6.02B	7.63%-1.74B	-31,050.00%-1.24B	-32.04%-2.28B	62.09%-754M
Gain on sale of security	-176.19%-58M	42.11%-11M	-766.67%-20M	-2,200.00%-23M	0.00%-4M	85.62%-21M	61.22%-19M	112.00%3M	97.30%-1M	88.57%-4M
Special income (charges)	-81.94%-5.02B	19.63%-1.27B	-3,168.29%-2.68B	12.17%-823M	-51.22%-248M	-254.37%-2.76B	-458.16%-1.57B	-24.24%-82M	-234.64%-937M	-9.33%-164M
-Less:Other special charges	81.94%5.02B	-19.63%1.27B	3,168.29%2.68B	-12.17%823M	51.22%248M	254.37%2.76B	458.16%1.57B	24.24%82M	234.64%937M	9.33%164M
Other non- operating income (expenses)	-78.80%-5.79B	-706.67%-1.21B	56.60%-503M	-96.21%-2.64B	-145.90%-1.44B	30.72%-3.24B	90.36%-150M	-1,320.00%-1.16B	4.75%-1.35B	67.52%-586M
Income before tax	77.53%6.6B	217.58%2.67B	-65.74%714M	-27.59%1.55B	-5.36%1.66B	-40.54%3.72B	-287.21%-2.27B	6.71%2.08B	-17.78%2.15B	269.47%1.76B
Income tax	514.74%2.36B	137.98%853M	1.15%526M	-20.70%613M	-2.87%372M	-141.39%-570M	-678.87%-2.25B	202.33%520M	32.59%773M	63.68%383M
Net income	-1.24%4.23B	7,991.30%1.82B	-87.98%188M	-31.46%941M	-6.05%1.29B	-12.05%4.29B	-102.79%-23M	-12.18%1.56B	-32.26%1.37B	469.29%1.37B
Net income continuous Operations	-1.24%4.23B	7,991.30%1.82B	-87.98%188M	-31.46%941M	-6.05%1.29B	-12.05%4.29B	-102.79%-23M	-12.18%1.56B	-32.26%1.37B	469.29%1.37B
Minority interest income	-12.50%7M	0.00%-1M	-33.33%2M	0.00%3M	0.00%3M	-20.00%8M	-150.00%-1M	0.00%3M	0.00%3M	50.00%3M
Net income attributable to the parent company	-1.22%4.23B	8,354.55%1.82B	-88.08%186M	-31.53%938M	-6.06%1.29B	-12.03%4.28B	-102.68%-22M	-12.20%1.56B	-32.31%1.37B	472.80%1.37B
Preferred stock dividends
Other preferred stock dividends	0.00%40M	0.00%10M	0.00%10M	0.00%10M	0.00%10M	-6.98%40M	-9.09%10M	-9.09%10M	-9.09%10M	-9.09%10M
Net income attributable to common stockholders	-1.23%4.19B	5,743.75%1.81B	-88.65%176M	-31.76%928M	-6.11%1.28B	-12.07%4.24B	-103.95%-32M	-12.22%1.55B	-32.44%1.36B	496.05%1.36B
Basic earnings per share	-1.25%2.37	8,342.16%1.0272	-88.64%0.1	-32.47%0.52	-6.49%0.72	-12.09%2.4	-102.68%-0.0125	-12.00%0.88	-32.46%0.77	492.31%0.77
Diluted earnings per share	-0.84%2.37	5,200.00%1.02	-88.64%0.1	-32.47%0.52	-6.49%0.72	-12.13%2.39	-104.35%-0.02	-12.00%0.88	-32.46%0.77	492.31%0.77
Dividend per share	5.81%6.56	5.81%1.64	5.81%1.64	5.81%1.64	5.81%1.64	4.73%6.2	4.73%1.55	4.73%1.55	4.73%1.55	4.73%1.55
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.